SCA
FLXN

Secor Capital Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Secor Capital Advisors’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,937
Closed -$214K – 656
2016
Q3 		$214K Buy
+10,937
New +$185K 0.02% 463

Other funds holding FLXN

GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Secor Capital Advisors's FLXN Position: Q4 2016 in Review

Secor Capital Advisors sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2016, closing a stake of 10,937 shares — an estimated $214K sold.

Secor Capital Advisors first reported a position in FLXN in Q3 2016 and held it in 1 quarter. The position peaked at $214K in Q3 2016. 94 funds tracked by Wall St. Rank hold FLXN as of Q4 2016.

  • Secor Capital Advisors reported no remaining Flexion Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Secor Capital Advisors sold 10,937 Flexion Therapeutics, Inc. shares in Q4 2016, an estimated $214K.
  • Secor Capital Advisors first reported a position in Flexion Therapeutics, Inc. in Q3 2016 and held it in 1 quarter.
  • Secor Capital Advisors's Flexion Therapeutics, Inc. position peaked at $214K in Q3 2016.
  • 94 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2016.

Based on Secor Capital Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.